Back
OptimizeRx Stock Price Chart
Sponsored
OPRX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
OPRX
OptimizeRx
Last Price:
4.49
Seasonality Move:
4.91%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
OptimizeRx Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.83 | Sell |
20-day SMA: | 5.28 | Sell |
50-day SMA: | 6.43 | Sell |
200-day SMA: | 10.05 | Sell |
8-day EMA: | 4.67 | Sell |
20-day EMA: | 5.27 | Sell |
50-day EMA: | 6.28 | Sell |
200-day EMA: | 9.13 | Sell |
OptimizeRx Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.59 | Sell |
Relative Strength Index (14 RSI): | 37.29 | Sell |
Chaikin Money Flow: | 294877 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.68 - 6.26) | Sell |
Bollinger Bands (100): | (6.03 - 9.63) | Sell |
OptimizeRx Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for OptimizeRx Stock
Is OptimizeRx Stock a Buy?
- OptimizeRx share price is 4.42 while OPRX 8-day simple moving average is 4.83, which is a Sell signal.
- The stock price of OPRX is 4.42 while OptimizeRx 20-day SMA is 5.28, which makes it a Sell.
- OptimizeRx 50-day simple moving average is 6.43 while OPRX share price is 4.42, making it a Sell technically.
- OPRX stock price is 4.42 and OptimizeRx 200-day simple moving average is 10.05, creating a Sell signal.
OPRX Technical Analysis vs Fundamental Analysis
Sell
46
OptimizeRx (OPRX)
is a Sell
Is OptimizeRx a Buy or a Sell?
-
OptimizeRx stock is rated a Sell
The current OptimizeRx [OPRX] share price is $4.42. The Score for OPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
OptimizeRx Stock Info
Market Cap:
81.42M
Price in USD:
4.42
Share Volume:
544.39K
OptimizeRx 52-Week Range
52-Week High:
16.65
52-Week Low:
3.78
Sell
46
OptimizeRx (OPRX)
is a Sell
OptimizeRx Share Price Forecast
-
What is the OptimizeRx stock price today?
The OptimizeRx stock price is 4.42 USD today. -
Will OPRX stock go up or go down?
OptimizeRx> share price is forecast to RISE/FALL based on technical indicators -
Is OptimizeRx overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, OptimizeRx is overvalued.
Is OptimizeRx Stock a Buy?
- OptimizeRx share price is 4.42 while OPRX 8-day exponential moving average is 4.67, which is a Sell signal.
- The stock price of OPRX is 4.42 while OptimizeRx 20-day EMA is 5.27, which makes it a Sell.
- OptimizeRx 50-day exponential moving average is 6.28 while OPRX share price is 4.42, making it a Sell technically.
- OPRX stock price is 4.42 and OptimizeRx 200-day simple moving average is 9.13, creating a Sell signal.
Fundamental Analysis of OptimizeRx
Is OptimizeRx a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.07 per share.
Technical Analysis of OptimizeRx
Should I short OptimizeRx stock?
- OPRX Moving Average Covergence Divergence (MACD) indicator is -0.59, suggesting OptimizeRx is a Sell
- OptimizeRx Relative Strength Index (RSI) is 37.29, which suggest OptimizeRx is oversold
- The Bollinger Bands (25) for OptimizeRx is (4.68 - 6.26), which suggest OptimizeRx is a Sell
- The Bollinger Bands (100) for OptimizeRx is (6.03 - 9.63), which suggest OptimizeRx is a Sell
* OptimizeRx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.